CSIMarket
 
Babylon Holdings Limited  (BBLN)
Other Ticker:  
 
 
Price: $0.5504 $-0.09 -13.987%
Day's High: $0.63 Week Perf: -11.23 %
Day's Low: $ 0.55 30 Day Perf: -7.5 %
Volume (M): 420 52 Wk High: $ 11.35
Volume (M$): $ 231 52 Wk Avg: $4.90
Open: $0.63 52 Wk Low: $0.46



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 25
 Employees -
 Revenues (TTM) (Millions $) 311
 Net Income (TTM) (Millions $) -63
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Babylon Holdings Limited
Babylon Holdings Limited is a technology company that provides healthcare services through its digital platform. It was founded in 2013 and is based in London, United Kingdom. The company offers virtual healthcare consultations, medical diagnostics, and health monitoring tools to users through its mobile application. Its platform utilizes artificial intelligence and machine learning algorithms to provide personalized healthcare recommendations and treatment plans. Babylon Holdings Limited aims to make healthcare more accessible and affordable for individuals globally.


   Company Address: 2500 Bee Cave Road Austin 78746 TX
   Company Phone Number: 967-3787   Stock Exchange / Ticker: NYSE BBLN
   BBLN is expected to report next financial results on March 15, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Arch Therapeutics Inc

Very strong data, by ARTH all along the financial time-frame closing Dec 31 2023

ARTH announced very strong Revenue elevation of 632.583 % year on year to $0.05 million in the financial time-frame closing Dec 31 2023, but lost money at $-0.57. ARTHs' has evidently exceeded its industry contemporaries on the top-line side, as the Medical Equipment and Supplies industry report 5.58% in the same period revenue elevation yet.

Inspiremd Inc

The investors are dealing with 0.489%, improvement at NSPR amid the third quarter of 2023 earnings season

For the most recent fiscal period NSPR decreased a loss per share of $-0.15 per share compare to $-0.58 a year prior and EPS improved from $-0.24 per share from the prior financial reporting period. The Revenue grew softly by 0.489 % to $1.44 million from $1.43 million in the similar financial reporting period a year prior and sequentially Revenue decreased by -3.555 % from $1.49 million. To putInspiremd Inc s'third quarter of 2023 conduct, the investors must take a look at all in allMedical Equipment and Supplies sectors, it is obvious, that Inspiremd Inc has under performed as the peers statement business improvement of 5.41% relative to the similar period a year ago.

Glucotrack Inc

The rising company from the Medical Equipment and Supplies market the GCTK issued the July to September 30 2023 period, numbers

While the earnings season of the July to September 30 2023 continues, many companies have declared the respective earnings. In the thick of it, have been multiple companies in the Medical Equipment and Supplies industry. As well as, now, GCTK issued operating profit of $2.224 million, for the July to September 30 2023 span.

Marizyme Inc

Marizyme Inc disclosed that the company went from strength to strength, in the third quarter of 2023 earnings season

MARZ announced very robust Revenue growth of 138.824 % year on year to $0.18 million in the third quarter of 2023 earnings season, but increased a deficit per share at $-0.71.

Intelligent Bio Solutions Inc

INBS Delivers Impressive Financial Results in Recent Fiscal Period

Intelligent Bio Solutions Inc (INBS) has seen significant improvements in its financial performance for the fiscal interval closing December 31, 2023. The company reported a decrease in loss per share from $-5.52 to $-2.07 compared to the previous year. This shows a positive trend in the company's financial health. Additionally, EPS improved from $-12.48 to an undisclosed amount, indicating positive growth and progress for the company.
One of the key highlights of INBS's performance is the sharp increase in revenue by 114.216% to $0.76 million from $0.36 million in the same reporting season a year ago. However, there was a slight sequential decrease of -4.024% from $0.80 million in the previous reporting season. Despite this, INBS's revenue growth in the second quarter of 2024 correlates favorably to its industry peers in the Medical Equipment and Supplies sector, who experienced an average business growth of 5.58% during the same period.






 

Babylon Holdings Limited's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com